RC48-ADC targets HER2 on the cell surface, is internalized, and releases MMAE, which binds beta-tubulin to disrupt microtubules and induce mitotic arrest/apoptosis; killing depends on HER2-mediated delivery (with possible bystander effect), not on beta-tubulin expression per se.